Advances in Gynecologic Cancer
A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Women's Health Care".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 299
Special Issue Editor
Special Issue Information
Dear Colleagues,
The most recent cancer statistics estimate that in the year 2022, 115,130 women will be diagnosed with a gynecologic cancer in the United States, and 32,830 women will die from ovarian, uterine, cervical, vulvar or vaginal cancer.
Gynecologic oncology is a rapidly evolving field. The past few years and months have been characterized by “game-changing” improvements in the prevention, diagnosis and management of gynecologic malignancies. Thanks to the HPV vaccine, we now have a potential tool to prevent the majority of cervical (and many vulvar) cancers. However, with fever than 10% of the target population being vaccinated, we are far from eliminating cervical cancer. Several landmark trials have changed the way we perform surgery in cervical, endometrial and ovarian cancers. Randomized controlled trials have improved our understanding of which patients benefit most from radiation therapy, and the approval of PARP and immune checkpoint inhibitors have fundamentally changed the systemic treatment of gynecologic cancers.
One of the driving factors in (gynecologic) cancer research that has enabled us to complete studies in a much shorter time is collaboration across institutions.
This Special Issue of Healthcare seeks original articles, reviews, commentaries and short reports on Advances in Gynecologic Oncology. This Issue aims to publish manuscripts on developments in the prevention, epidemiology, diagnosis and management of gynecologic cancer, each of which will serve as a piece of the puzzle to further improve care for women with gynecologic malignancies.
Dr. Christoph Wohlmuth
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic cancer
- ovarian cancer
- cervical cancer
- vulvar cancer
- endometrial cancer
- uterine cancer
